Literature DB >> 27778404

Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury.

Lutz Menzel1, Lisa Kleber1, Carina Friedrich1, Regina Hummel1, Larissa Dangel1, Jennifer Winter2,3, Katja Schmitz4, Irmgard Tegeder4, Michael K E Schäfer1,3.   

Abstract

In response to traumatic brain injury (TBI) microglia/macrophages and astrocytes release inflammatory mediators with dual effects on secondary brain damage progression. The neurotrophic and anti-inflammatory glycoprotein progranulin (PGRN) attenuates neuronal damage and microglia/macrophage activation in brain injury but mechanisms are still elusive. Here, we studied histopathology, neurology and gene expression of inflammatory markers in PGRN-deficient mice (Grn-/- ) 24 h and 5 days after experimental TBI. Grn-/- mice displayed increased perilesional axonal injury even though the overall brain tissue loss and neurological consequences were similar to wild-type mice. Brain inflammation was elevated in Grn-/- mice as reflected by increased transcription of pro-inflammatory cytokines TNFα, IL-1β, IL-6, and decreased transcription of the anti-inflammatory cytokine IL-10. However, numbers of Iba1+ microglia/macrophages and immigrated CD45+ leukocytes were similar at perilesional sites while determination of IgG extravasation suggested stronger impairment of blood brain barrier integrity in Grn-/- compared to wild-type mice. Most strikingly, Grn-/- mice displayed exaggerated astrogliosis 5 days after TBI as demonstrated by anti-GFAP immunohistochemistry and immunoblot. GFAP+ astrocytes at perilesional sites were immunolabelled for iNOS and TNFα suggesting that pro-inflammatory activation of astrocytes was attenuated by PGRN. Accordingly, recombinant PGRN (rPGRN) attenuated LPS- and cytokine-evoked iNOS and TNFα mRNA expression in cultured astrocytes. Moreover, intracerebroventricular administration of rPGRN immediately before trauma reduced brain damage and neurological deficits, and restored normal levels of cytokine transcription, axonal injury and astrogliosis 5 days after TBI in Grn-/- mice. Our results show that endogenous and recombinant PGRN limit axonal injury and astrogliosis and suggest therapeutic potential of PGRN in TBI. GLIA 2017;65:278-292.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  TNFα; astrocytes; neuroinflammation; progranulin; traumatic brain injury

Mesh:

Substances:

Year:  2016        PMID: 27778404     DOI: 10.1002/glia.23091

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  26 in total

Review 1.  Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Arshdeep S Dhaliwal; Iuliia Dubova; Shireen Mentor; Keerthivaas Premkumar; Daniyal Saeed; Haris Zahoor; Sudhanshu P Raikwar; Smita Zaheer; Shankar S Iyer; Asgar Zaheer
Journal:  Neuroscientist       Date:  2019-05-16       Impact factor: 7.519

2.  Neurovascular dysfunction in GRN-associated frontotemporal dementia identified by single-nucleus RNA sequencing of human cerebral cortex.

Authors:  John C van Swieten; Bart J L Eggen; Emma Gerrits; Lucia A A Giannini; Nieske Brouwer; Shamiram Melhem; Danielle Seilhean; Isabelle Le Ber; Alwin Kamermans; Gijs Kooij; Helga E de Vries; Erik W G M Boddeke; Harro Seelaar
Journal:  Nat Neurosci       Date:  2022-07-25       Impact factor: 28.771

3.  Administration of all-trans retinoic acid after experimental traumatic brain injury is brain protective.

Authors:  Regina Hummel; Sebastian Ulbrich; Dominik Appel; Shuailong Li; Tobias Hirnet; Sonja Zander; Wieslawa Bobkiewicz; Christina Gölz; Michael K E Schäfer
Journal:  Br J Pharmacol       Date:  2020-10-23       Impact factor: 8.739

Review 4.  Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets.

Authors:  Suraj Sulhan; Kristopher A Lyon; Lee A Shapiro; Jason H Huang
Journal:  J Neurosci Res       Date:  2018-09-27       Impact factor: 4.164

Review 5.  Unravelling neuroinflammation in abusive head trauma with radiotracer imaging.

Authors:  Rahul M Nikam; Xuyi Yue; Vinay V Kandula; Bishnuhari Paudyal; Sigrid A Langhans; Lauren W Averill; Arabinda K Choudhary
Journal:  Pediatr Radiol       Date:  2021-05-17

6.  Pharmacologic Inhibition of ADAM10 Attenuates Brain Tissue Loss, Axonal Injury and Pro-inflammatory Gene Expression Following Traumatic Brain Injury in Mice.

Authors:  Dominik Appel; Regina Hummel; Martin Weidemeier; Kristina Endres; Christina Gölz; Michael K E Schäfer
Journal:  Front Cell Dev Biol       Date:  2021-03-15

7.  Resveratrol Attenuates Microglial Activation via SIRT1-SOCS1 Pathway.

Authors:  Shuping Zhang; Lu Gao; Xiuying Liu; Tao Lu; Chuangbo Xie; Ji Jia
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-11       Impact factor: 2.629

Review 8.  Microglial Activation in Traumatic Brain Injury.

Authors:  Cornelius K Donat; Gregory Scott; Steve M Gentleman; Magdalena Sastre
Journal:  Front Aging Neurosci       Date:  2017-06-28       Impact factor: 5.750

9.  Progranulin deficiency causes the retinal ganglion cell loss during development.

Authors:  Yoshiki Kuse; Kazuhiro Tsuruma; Takahiro Mizoguchi; Masamitsu Shimazawa; Hideaki Hara
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

Review 10.  Brain-gut axis dysfunction in the pathogenesis of traumatic brain injury.

Authors:  Marie Hanscom; David J Loane; Terez Shea-Donohue
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.